Related Experiment Video
Updated: Sep 22, 2025
08:49
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.3K
PLSec: A novel, liquid biomarker for HCC risk
Joseph W Franses1, Irun Bhan2, Andrew X Zhu3
1Massachusetts General Hospital Division of Hematology-Oncology, Harvard Medical School, Boston, MA 02114, USA.
Med (New York, N.Y.)
|May 19, 2022
Abstract:
Cirrhosis confers a variable risk of developing hepatocellular carcinoma (HCC), but the risk varies significantly depending upon ill-defined factors. In this issue of Med, Fujiwara et al.1 use hepatic gene signatures and computational analysis to develop a streamlined, robust blood-based predictor of HCC risk in this population.
